OertliKatalyst introduces vitreoretinal hand instruments


Oertli has introduced OertliKatalyst, a new brand in conjunction with Katalyst.

Oertli has introduced OertliKatalyst, a new brand in conjunction with Katalyst.

OertliKatalyst consists of a new handpiece set, innovative tip geometrics, a choice of material and improved implementation of ergonomic basic principles. The brand has been developed from scratch and has resulted in numerous patent registrations.

Thomas Bosshard, Head of Marketing and Sales at Oertli, said, " We were looking for the right moment to launch and the right moment to bring the right combination of vitreo hand instruments. We looked at things like laser probes and forceps, scissors, polishers and so on. We wanted the right partner at the right moment and the right resources."

The retinal instruments were first launched at this year's ESCRS congress in Milan. CEO of Katalyst, Greg Scheller, commented, "They feature about 15 new tip designs that have not been previously available in the vitreoretinal market. We also have laser probes that have not yet been introduced in the world market. But they have in the US, as well as diamond membrane polishers. We will be introducing a continuous line of products as both companies move forward."

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.